New “Nicotine Engagement” ETF Challenges ESG, Bets on Reforming Tobacco

NEW YORK, NY – May 08, 2026 – A new and controversial exchange-traded fund is challenging the core tenets of ethical investing, arguing that the best way to deal with Big Tobacco is not to shun it, but to buy into it and force change from the inside. Hexis Capital Management launched the Hexis Active Nicotine Engagement ETF (NYSE: NICO) this week, an actively managed fund that invests directly in the global nicotine sector while deploying what it calls a “structured engagement program” to accelerate the industry’s pivot away from combustible cigarettes.

The fund, which began trading on the New York Stock Exchange on May 6, represents a direct challenge to the prevailing ESG (Environmental, Social, and Governance) orthodoxy of divestment. For years, asset managers have excluded so-called “sin stocks” from their portfolios to appease ethically-minded investors. Hexis Capital is betting that this approach has failed to produce meaningful change and that a new strategy is needed.

“For too long, many investors who care about public health have felt forced to exclude the nicotine sector entirely, leaving the pace of industry transformation in fewer hands,” said Pieter Vorster, Founder and CEO of Hexis Capital Management, in a statement announcing the launch. Vorster, a 30-year investment analyst with two decades focused on the tobacco sector, argues the industry is already in a major transition. “NICO was created to give investors a way to participate in that transition while actively engaging with companies to accelerate it.”

A New Playbook for “Sin Stocks”

The ETF’s strategy is to capitalize on and influence the industry’s shift toward reduced-risk products (RRPs). These include tobacco-heating systems like Philip Morris International’s IQOS and oral nicotine pouches such as PMI’s Zyn brand, which are already driving significant growth and valuation shifts across the sector. Rather than simply buying a basket of tobacco stocks, NICO aims to be an active owner, using its stake to hold companies accountable for their transition promises.

The fund enters a market where the lines are clearly drawn. Major public health organizations and anti-tobacco groups have long advocated for complete divestment and non-engagement, viewing the industry’s interests as fundamentally irreconcilable with public health goals. NICO’s approach wades directly into this contentious space, arguing that engagement is a more powerful tool for harm reduction than exclusion.

“Real change in this industry will come from sustained, evidence-based engagement with the companies that hold the most influence over the pace of transition,” stated Jonathan Fell, Head of Research and Engagement at Hexis Capital Management. “Our role is to bring rigor and accountability to that conversation, on behalf of investors and in service of better public health outcomes.”

The Brains Behind the Bet: Data and Governance

At the heart of the fund’s strategy is the proprietary Hexis Nicotine Transition Score (HNTS). This complex framework evaluates companies based on 27 distinct indicators and 13 sub-indicators, measuring their progress in moving away from combustible tobacco. In a nod to modern data analytics, approximately 20% of the score is derived from AI-supported indicators that track patent filings, hiring trends for RRP specialists, and market sentiment.

This data-driven score, which has been independently reviewed by advisory firm ACA Ethos, directly informs the fund’s portfolio construction and its engagement priorities with corporate management. The goal is to create a quantifiable, objective basis for rewarding companies that are genuinely transforming and pressuring those that are lagging.

To bolster its credibility, Hexis has assembled a team of industry and public health veterans. The fund’s engagement program was designed by Tim Youmans, a recognized authority in corporate governance. Perhaps most notably, oversight is provided by an independent Harm Reduction Stewardship Council, chaired by Dr. Derek Yach. Dr. Yach’s involvement is particularly striking, as he previously spearheaded the development of the World Health Organization’s Framework Convention on Tobacco Control (FCTC), the landmark global treaty that guides anti-tobacco policy worldwide.

A Bridge Too Far? The Public Health Standoff

Dr. Yach’s presence on the council highlights the central conflict at the heart of the NICO ETF. The WHO’s FCTC, which he helped create, explicitly warns against partnering with the tobacco industry. The WHO’s official stance remains one of zero engagement, arguing that the industry has a long history of using such collaborations to whitewash its image and undermine public health policy.

Public health organizations almost universally echo this position, contending that the tobacco industry’s core business remains fundamentally harmful and that its interests cannot be aligned with health objectives. They also express deep skepticism about the industry’s promotion of reduced-risk products. The WHO, for instance, has stated there is insufficient independent evidence to conclude that heated tobacco products are less harmful than conventional cigarettes.

This puts the NICO ETF in a precarious position. It seeks to occupy a middle ground that many in the public health community believe does not, and should not, exist. The fund’s success depends on convincing investors that its engagement is not a cynical marketing ploy but a genuine mechanism for change, even as the world’s leading health bodies advocate for the opposite approach.

Wall Street's Reaction and the ESG Crossroads

With a modest $1.01 million in assets under management and a management fee of 0.70%, NICO is starting as a small, niche experiment. Its initial trading volumes are low, reflecting the novelty and controversy of its proposition. However, its launch comes at a time when the broader ESG investing movement is facing its own identity crisis.

Critics have argued that simple exclusion-based ESG strategies are often ineffective and that ESG rating systems can produce paradoxical results, sometimes rewarding tobacco companies for strong operational management while ignoring the inherent harm of their products. By proposing a complex, data-driven engagement model, Hexis is offering a potential new path forward for investors who are dissatisfied with the status quo.

The question now is whether the market is ready for such a nuanced approach. The NICO ETF is a test case for whether investors can stomach profiting from nicotine while pushing for harm reduction. Its performance will be watched closely not just by financial analysts, but by public health advocates and ESG strategists, as it could set a precedent for how investors engage with controversial industries for years to come.